Filing Flows › Niagen Bioscience (NAGE) › Q2 2025
Niagen Bioscience (NAGE) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 6, 2025
Niagen Bioscience (NAGE) reported revenue of $31.1M for the second quarter 2025 (Q2 2025), +37% from a year earlier and +2% from the quarter before. Operating margin was 10.2%, net earnings $3.6M (11.6% of revenue).
Niagen Bioscience, Q2 2025: revenue $31.1M (+37% year over year), operating margin 10.2%, net earnings $3.6M, operating cash flow $1.2M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $31.1M | +2% | +37% |
| Gross profit | $20.2M | +5% | +48% |
| Operating profit | $3.2M | -33% | — |
| Net earnings | $3.6M | -29% | — |
| Operating cash flow | $1.2M | -84% | — |
What changed
Revenue was $31.1M in Q2 2025, up 37% year over year and up 2% from the previous quarter. Consumer Products segment was the largest line at 73% of revenue. Ingredients segment added $4.3M year over year (up 131%), 52% of the total change.
Gross margin was 65.0%, up 4.8 points from a year earlier. Operating profit was $3.2M, a 10.2% margin (up 11.4 points year over year). Operating expenses grew 22% against revenue growth of 37%. The fastest-growing cost line was General & admin (+28%). Net earnings were $3.6M. The effective tax rate was 3.4%.
Operating cash flow was $1.2M, 35% of net earnings. Non-cash charges added back $196K of depreciation and amortization and $1.5M of share-based compensation. Working capital and other items used $4.0M.
Questions
What was Niagen Bioscience's revenue in the second quarter 2025?
Niagen Bioscience (NAGE) reported revenue of $31.1M for the second quarter 2025 (Q2 2025), +37% from a year earlier and +2% from the quarter before.
Was Niagen Bioscience profitable in the second quarter 2025?
Operating profit was $3.2M (10.2% of revenue) and net earnings $3.6M.
Source: Niagen Bioscience 10-Q on SEC EDGAR.